These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27857122)
1. Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line. Dowling JJ Nat Rev Neurol; 2016 Dec; 12(12):675-676. PubMed ID: 27857122 [No Abstract] [Full Text] [Related]
2. Antisense oligonucleotide drugs for Duchenne muscular dystrophy: how far have we come and what does the future hold? Guncay A; Yokota T Future Med Chem; 2015; 7(13):1631-5. PubMed ID: 26423833 [No Abstract] [Full Text] [Related]
3. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Mendell JR; Goemans N; Lowes LP; Alfano LN; Berry K; Shao J; Kaye EM; Mercuri E; Ann Neurol; 2016 Feb; 79(2):257-71. PubMed ID: 26573217 [TBL] [Abstract][Full Text] [Related]
4. Why dystrophin quantification is key in the eteplirsen saga. Aartsma-Rus A; Arechavala-Gomeza V Nat Rev Neurol; 2018 Aug; 14(8):454-456. PubMed ID: 29967362 [No Abstract] [Full Text] [Related]
5. Eteplirsen for the Treatment of Duchenne Muscular Dystrophy: Quality of Evidence Concerns-an Alternative Viewpoint. Irwin AN; Herink MC Pharmacotherapy; 2017 Oct; 37(10):e109-e111. PubMed ID: 28741800 [No Abstract] [Full Text] [Related]
6. Eteplirsen (Exondys 51) for duchenne muscular dystrophy. Med Lett Drugs Ther; 2016 Nov; 58(1507):145-146. PubMed ID: 27805575 [No Abstract] [Full Text] [Related]
7. Eteplirsen: First Global Approval. Syed YY Drugs; 2016 Nov; 76(17):1699-1704. PubMed ID: 27807823 [TBL] [Abstract][Full Text] [Related]
8. Eteplirsen in the treatment of Duchenne muscular dystrophy. Lim KR; Maruyama R; Yokota T Drug Des Devel Ther; 2017; 11():533-545. PubMed ID: 28280301 [TBL] [Abstract][Full Text] [Related]
9. FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga. Aartsma-Rus A; Krieg AM Nucleic Acid Ther; 2017 Feb; 27(1):1-3. PubMed ID: 27929755 [No Abstract] [Full Text] [Related]
10. Exon skipping therapy for Duchenne muscular dystrophy. Kole R; Krieg AM Adv Drug Deliv Rev; 2015 Jun; 87():104-7. PubMed ID: 25980936 [TBL] [Abstract][Full Text] [Related]
11. Eteplirsen for paediatric patients with Duchenne muscular dystrophy: A pooled-analysis. Randeree L; Eslick GD J Clin Neurosci; 2018 Mar; 49():1-6. PubMed ID: 29254734 [TBL] [Abstract][Full Text] [Related]
13. Restoration of Walking After Surgical Management of Equinus in a Non-ambulatory Child With Duchenne Muscular Dystrophy: A Case Presentation. Bouchard M; Vogel LF; Apkon SD PM R; 2019 Nov; 11(11):1240-1243. PubMed ID: 30859710 [No Abstract] [Full Text] [Related]